Alina M Constantin

Alina M Constantin

Auto-generated profile, based on publicly available information

Alina M Constantin

British Association of Dermatologists , Willan House, London

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2024 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
MHMatthew Harries
Matthew Harries
AAAnna Ascott
Anna Ascott
LALeila Asfour
Leila Asfour
PFPaul Farrant
Paul Farrant
GHGordon Hale
Gordon Hale
BUBritish Association of Dermatologists’ Clinical Standards Unit
British Association of Dermatologists’ Clinical Standards Unit
Lay Summary: Alopecia areata (AA) is a long-term condition that can occur in both children and adults. AA can appear as patches of baldness on the scalp. Sometimes, nail growth is also affected. Hair on other parts of the body may also fall out, such as the beard, eyebrows and eyelashes. Total loss of scalp hair is called alopecia totalis (AT). Complete loss of scalp, facial and body hair is called alopecia universalis (AU). The British Association of Dermatologists gathered a group of experts in managing people of all ages with AA. The group consisted of 11 dermatologists, 1 psychologist, 2 people with AA and a team with expertise in preparing guidelines. This group of experts reviewed relevant studies published until 19 October 2023. Using the evidence, the group produced recommendations using rigorous standards for guideline development. The guideline development group produced 49 recommendations for management of people with AA. They also made 7 recommendations for future research and suggested 11 audit points for hospitals. Based on the guideline, the group prepared an updated patient information leaflet. The leaflet is available on the British Association of Dermatologists’ website (https://www.skinhealthinfo.org.uk/condition/alopecia-areata).

22 September 2023 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
CSCatherine H Smith
Catherine H Smith
ZYZenas Z N Yiu
Zenas Z N Yiu
TBTracy Bale
Tracy Bale
ABA David Burden
A David Burden
LCLaura C Coates
Laura C Coates
MMM Firouz Mohd Mustapa
M Firouz Mohd Mustapa
The article provides a pragmatic update of the British Association of Dermatologists guidelines for biologic therapy for psoriasis.

10 September 2024 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
RMRuth Murphy
Ruth Murphy
RMRobert J Moots
Robert J Moots
PBPaul Brogan
Paul Brogan
AÇAykut F Çelik
Aykut F Çelik
MCMark Clement-Jones
Mark Clement-Jones
ACAlina M Constantin
Alina M Constantin
The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of Behçets. The document aims to offer an appraisal of all relevant literature up to 25 August 2023 focusing on any key developments; to address important, practical clinical questions relating to the primary guideline objective; and to provide guideline recommendations and appropriate research recommendations.

14 November 2025 in British Journal of Dermatology
Verified
Journal Article
Closed access
MHMatthew Harries
Matthew Harries
AAAlia Ahmed
Alia Ahmed
AAAnna Ascott
Anna Ascott
KBKashif Bhatti
Kashif Bhatti
JEJoseph Earley
Joseph Earley
ACAlina M Constantin
Alina M Constantin
Lay Summary: Alopecia areata (AA) is a long-term condition that can occur in both children and adults. AA can appear as patches of baldness on the scalp. Sometimes, nail growth is also affected. Hair on other parts of the body may also fall out, such as the beard, eyebrows and eyelashes. Alopecia totalis is the name for total loss of scalp hair. Alopecia universalis is complete loss of scalp, facial and body hair. This is the second version of the guideline. The British Association of Dermatologists gathered a group of experts in managing people of all ages with AA. The group consisted of eight consultant dermatologists, one dermatology specialist registrar, one general practitioner, one psychologist, two people with AA and a team with expertise in preparing guidelines. This group of experts reviewed relevant studies published until 11 July 2025. Using the evidence, the group produced recommendations using rigorous standards for guideline development. The guideline development group produced 56 recommendations for management of people with AA. They also made 9 recommendations for future research and suggested 11 audit points for hospitals. Based on the guideline, a patient information leaflet is also available on the British Association of Dermatologists’ website (https://www.skinhealthinfo.org.uk/condition/alopecia-areata).

29 September 2025 in British Journal of Dermatology
Verified
Journal Article
Closed access
RMRuth Murphy
Ruth Murphy
RMRobert J Moots
Robert J Moots
PBPaul Brogan
Paul Brogan
AÇAykut F Çelik
Aykut F Çelik
MCMark Clement-Jones
Mark Clement-Jones
ACAlina M Constantin
Alina M Constantin
The overall objective of this living guideline with a fixed-interval schedule is to provide up-to-date, evidence-based recommendations for the management of Behçets disease/syndrome in adults, children and young people. The literature will be reviewed at least every 6 months, with a living guideline updating cycle of 12 months. The current iteration aims to: (i) offer an appraisal of all relevant literature up to 23 May 2025 focusing on any key developments; (ii) address important, practical clinical questions relating to the primary guideline objective; and (iii) provide guideline recommendations and appropriate research recommendations.

18 April 2026 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PJPooja Jassal-Prior
Pooja Jassal-Prior
AHAmaani B Hussain
Amaani B Hussain
ACAlina M Constantin
Alina M Constantin
BKBrian Kirby
Brian Kirby
PLPhilip Laws
Philip Laws
ZYZenas Z N Yiu
Zenas Z N Yiu
Stakeholder engagement is best practice for guideline development and implementation. We therefore aimed to gather evidence in the form of a cross-sectional survey of patients’ and healthcare professionals’ research priorities for the British Association of Dermatologists methotrexate guideline.